Potential mechanisms linking probiotics to diabetes: a narrative review of the literature

Miraghajani, Maryam; Dehsoukhteh, Somayeh Shahraki; Rafie, Nahid; Hamedani, Sahar Golpour; Sabihi, Sima; Ghiasvand, Reza

doi:10.1590/1516-3180.2016.0311271216

Cited by 48 publications

(28 citation statements)

References 49 publications

(117 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This result is the first evidence reported in the literature, and we speculate that it could be attributed to the capacity of probiotics to decrease the intestinal permeability with a consequent reduction of lipopolysaccharide and inflammatory cytokine levels [58]. …”

Section: Discussionmentioning

confidence: 52%

Evidences of a New Psychobiotic Formulation on Body Composition and Anxiety

Colica

Avolio

Bollero

et al. 2017

Mediators of Inflammation

View full text Add to dashboard Cite

Background Gut microbiota is implied in obesity, because of its ability to harvest energy from diet, and in the regulation of behavior. Given the link between gut microbiota, body composition, obesity, and anxiety, the aim of this study was to evaluate the effects of a new psychobiotic formulation. Methods Eligible patients were randomly divided into three groups: psychobiotics oral suspension group (POSG); dietary treatment group (DTG); combined treatment group (CTG). All subjects underwent body composition and psychological profile evaluation. Results Significant changes in body composition parameters in each group were relieved after all treatments. Hamilton anxiety rating scale (HAM-A) highlighted a significant reduction of the total score for all study population after treatments in POSG (p = 0.01) and CTG (p = 0.04). A reduction of HAM-A total score in anxious subjects in POSG or CTG and a significant reduction of positive subjects for HAM-A in POSG (p = 0.03) and in CDG (p = 0.01) were shown. Discussion Three-week intake of selected POS represents a good approach to solve problems related to obesity and behavior disorders. However, new clinical trials need to be performed on a larger population and for a longer period of treatment before definitive conclusions can be made. This trial is registered with NCT01890070.

show abstract

Section: Discussionmentioning

confidence: 52%

Evidences of a New Psychobiotic Formulation on Body Composition and Anxiety

Colica

Avolio

Bollero

et al. 2017

Mediators of Inflammation

View full text Add to dashboard Cite

show abstract

“…A recent systematic review with DM2 patients showed that the use of probiotics reduced fasting blood glucose (in 19 studies), glycated haemoglobin (in 13 studies), insulin (in 13 studies) and HOMA-IR (in 10 studies) 13 . The potential mechanisms of probiotics actions on glycemic control are: 1) direct intraluminal effects on the microbiota, with increase in the production of short-chain fatty acids (SCFAs), intestinal permeability reduction and lipopolysaccharides, and increases the production of glucagon-like peptide 1 (GLP-1); 2) anti-inflammatory and immunomodulatory effects, with reduction of pro-inflammatory cytokines; 3) reduction of oxidative stress, with protective effect of beta cells; 4) effects of gene expression involved in glucose homeostasis and insulin resistance, as sensitization increases via GLUT-4 17 .…”

Section: Discussionmentioning

confidence: 99%

Effects of Probiotics Supplementation on Skin Wound Healing in Diabetic Rats

Campos

Tagliari

Casagrande

et al. 2020

ABCD, arq. bras. cir. dig.

View full text Add to dashboard Cite

Background: Chronic wounds in patients with Diabetes Mellitus often become incurable due to prolonged and excessive production of inflammatory cytokines. The use of probiotics modifies the intestinal microbiota and modulates inflammatory reactions. Aim: To evaluate the influence of perioperative supplementation with probiotics in the cutaneous healing process in diabetic rats. Methods: Forty-six rats were divided into four groups (C3, P3, C10, P10) according to the treatment (P=probiotic or C=control, both orally administered) and day of euthanasia, 3rd or 10th postoperative days. All rats were induced to Diabetes Mellitus 72 h before starting the experiment with alloxan. Supplementation was initiated five days before the incision and maintained until euthanasia. Scalpel incision was guided by a 2x2 cm mold and the wounds were left to heal per second-intention. The wounds were digitally measured. Collagen densitometry was done with Picrosirius Red staining. Histological parameters were analyzed by staining by H&E. Results: The contraction of the wound was faster in the P10 group which resulted in a smaller scar area (p=0.011). There was an increase in type I collagen deposition from the 3rd to the 10th postoperative day in the probiotic groups (p=0.016), which did not occur in the control group (p=0.487). The histological analysis showed a better degree of healing in the P10 group (p=0.005), with fewer polymorphonuclear (p<0.001) and more neovessels (p=0.001). Conclusions: Perioperative supplementation of probiotics stimulates skin wound healing in diabetic rats, possibly due to attenuation of the inflammatory response and increased neovascularization and type I collagen deposition.

show abstract

“…Pepck and G6pc are key enzymes in a gluconeogenesis process. Pepck is an enzyme that catalyzes the synthesis of glucose-6-phosphate from noncarbohydrate precursors, while G6pc catalyzes the dephosphorylation of glucose-6phosphate to glucose, and this reaction is the last reaction step in gluconeogenesis [17]. Consumption of probiotics has been reported to ameliorate hyperglycemia [18][19][20][21][22][23][24].…”

Section: Introductionmentioning

confidence: 99%

Lactobacillus rhamnosusReduces Blood Glucose Level through Downregulation of Gluconeogenesis Gene Expression in Streptozotocin-Induced Diabetic Rats

Farida

Nuraida

Giriwono

et al. 2020

International Journal of Food Science

View full text Add to dashboard Cite

Some lactic acid bacteria (LAB) are observed to be potential probiotics with functional properties such as lowering fasting blood glucose (FBG), as a promising hyperglycemia management. This study investigated the ability and mechanism of Lactobacillus rhamnosus BSL and Lactobacillus rhamnosus R23 on lowering FBG in diabetic rats induced by streptozotocin (STZ). The rats were orally administered with L. rhamnosus BSL and L. rhamnosus R23 by giving 1 mL cell suspension (109 CFU/mL) daily for 30 days. The body weight (BW) was recorded once in three days, and FBG was recorded once in six days. An oral glucose tolerance test (OGTT) was measured 1 week after injection with STZ and before sacrifice. Fecal samples were collected on days 0, 15, and 30 for LAB population and identification, performed by PCR detecting 16S rRNA. Oral administration of L. rhamnosus BSL and L. rhamnosus R23 decreased FBG and improved glucose tolerance via downregulation of glucose-6-phosphatase (G6pc) expression by 0.57- and 0.60-fold change, respectively (P<0.05). The lipid profiles, BUN, creatinine, SGOT, and SGPT were significantly (P<0.05) different between normal and diabetic rats, but they were not significantly (P>0.05) different among diabetic rats. Both strains were effective in increasing fecal LAB population. Molecular identification of the isolated LAB from fecal sample indicated that they were able to survive and pass through the digestive tract. These results suggested that both strains have the ability to manage blood glucose level and become a promising agent to manage hyperglycemia and diabetes.

show abstract

Potential mechanisms linking probiotics to diabetes: a narrative review of the literature

Cited by 48 publications

References 49 publications

Evidences of a New Psychobiotic Formulation on Body Composition and Anxiety

Evidences of a New Psychobiotic Formulation on Body Composition and Anxiety

Effects of Probiotics Supplementation on Skin Wound Healing in Diabetic Rats

Lactobacillus rhamnosusReduces Blood Glucose Level through Downregulation of Gluconeogenesis Gene Expression in Streptozotocin-Induced Diabetic Rats

Contact Info

Product

Resources

About